Mode
Text Size
Log in / Sign up

Secondary Analysis of RCT Reports Higher Baseline GI Symptom Severity in Women Across Most DomainsMediterranean Diet Eases Stomach Troubles in High-Risk Adults

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider baseline gender differences in GI symptoms when evaluating adults with increased cardiometabolic risk in this secondary analysis.

This study represents a secondary analysis of a randomized controlled trial conducted in New Zealand. The population consisted of 200 adults with increased cardiometabolic risk. The intervention involved a 12-week New Zealand-adapted Mediterranean diet and behavioral intervention. Follow-up duration was 12 weeks. The primary outcome assessed gastrointestinal symptom severity using the GSRS.

Specific details regarding the comparator group were not reported in the available data. Similarly, the study phase and publication type were not reported. The secondary outcomes included health-related quality of life assessed by SF-36 and the influence of participant characteristics on symptoms. No specific comparator intervention details were provided for this analysis.

Regarding main results, baseline gastrointestinal symptom severity scores were analyzed by gender. Women reported significantly higher baseline gastrointestinal symptom severity scores on average across all GSRS domains except reflux. Results showed p < 0.05. Effect size and absolute numbers were not reported. This indicates a statistically significant difference in baseline characteristics between genders.

Safety and tolerability data were not reported, including adverse events, serious adverse events, and discontinuations. No limitations were listed in the provided JSON structure. Practice relevance was not reported. Clinicians should interpret these baseline findings cautiously as they do not reflect intervention efficacy directly. The study highlights baseline demographic variations rather than treatment outcomes.

A Surprising Side Effect of Eating Well

Maria, 52, has watched her blood pressure and cholesterol creep up for years. Her doctor told her to eat better, but Maria also deals with constant bloating and stomach pain after meals. She assumed her gut issues were just something she had to live with.

Then she tried a Mediterranean-style diet. Within weeks, her stomach felt calmer—and her heart health numbers improved, too.

This isn’t just a story about one person. New research suggests that for many adults at risk for heart disease and diabetes, changing how you eat can help both your heart and your gut at the same time.

Cardiometabolic diseases—like heart disease, stroke, and type 2 diabetes—are among the top health threats worldwide. They’re often linked to poor diets and digestive problems.

Many people with high blood pressure, high cholesterol, or extra weight also report stomach issues like bloating, pain, or irregular bowel movements. These gut problems can make daily life uncomfortable and even affect mental health.

Doctors often recommend the Mediterranean diet for heart health. It’s rich in fruits, vegetables, whole grains, olive oil, and fish, and low in red meat and processed foods. But until now, we didn’t know much about how this diet affects gut symptoms in people at high risk for heart disease.

For years, doctors focused on heart health when recommending the Mediterranean diet. Gut symptoms were often treated separately—with medications, fiber supplements, or elimination diets.

But here’s the twist: This study suggests that fixing your diet might help both problems at once. Instead of treating heart risk and gut issues separately, one simple change could address both.

Think of your gut like a busy highway. When you eat processed foods high in sugar and unhealthy fats, it’s like adding too many cars to the road—traffic jams, honking, and breakdowns happen. That’s your bloating, pain, and discomfort.

The Mediterranean diet is like clearing the highway. It’s full of fiber from fruits and veggies, which keeps traffic moving smoothly. Olive oil and nuts provide healthy fats that don’t clog the system. Fish adds protein without the heavy load of red meat.

This diet also feeds the good bacteria in your gut. These tiny helpers produce substances that reduce inflammation, which can calm both your stomach and your heart.

Researchers looked at data from a 12-week study of 200 adults in New Zealand. All participants had increased risk for heart disease or diabetes. Half followed a New Zealand-adapted Mediterranean diet with coaching, while the other half received general healthy eating advice.

Researchers measured gut symptoms using a standard questionnaire and tracked quality of life with a well-known survey.

The results were encouraging. People on the Mediterranean diet reported fewer gut symptoms overall, especially stomach pain and bloating.

Women, in particular, saw bigger improvements. They started with worse gut symptoms than men, but after 12 weeks, their scores improved significantly.

The study also found a strong link between gut symptoms and quality of life. When gut symptoms improved, people reported feeling better overall—more energy, less stress, and better sleep.

Here’s the key: These improvements happened while participants were also improving their heart health markers, like blood pressure and cholesterol.

A Pattern Interrupt

But there’s a catch.

This study adds to growing evidence that diet affects more than just your weight or cholesterol. What you eat can directly influence how you feel day to day, including gut comfort.

However, this was a secondary analysis, meaning the main study wasn’t designed to test gut symptoms specifically. That means the findings are promising but not definitive.

If you have high blood pressure, high cholesterol, or weight concerns—and you also struggle with gut issues—this research suggests that a Mediterranean-style diet could help both problems.

You don’t need a special prescription. You can start by adding more fruits, vegetables, whole grains, olive oil, and fish to your meals, and cutting back on red meat and processed foods.

This doesn’t mean this treatment is available yet. It’s still a dietary approach, not a medication, and results can vary.

This study had some important limits. It was a secondary analysis, so the main study wasn’t focused on gut symptoms. The participants were mostly middle-aged adults in New Zealand, so results may not apply to everyone. Also, the study lasted only 12 weeks, so we don’t know if the benefits last long-term.

Next, researchers need to design studies specifically testing the Mediterranean diet for gut symptoms. Longer trials could show whether the benefits stick over time. If results hold up, this could become a standard recommendation for people with both heart risk and gut issues.

For now, the evidence suggests that eating more Mediterranean-style foods is a safe, healthy choice that may help your heart and your gut at the same time.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
Background/objectivesCardiometabolic diseases are a major global health concern, and their development are linked to suboptimal dietary patterns and adverse gastrointestinal (GI) health outcomes and symptoms. Mediterranean dietary patterns are associated with reduced cardiometabolic disease risk and improved quality of life (QoL). The potential impact of the Mediterranean diet on GI symptoms is an important area of inquiry that requires elucidation. This study aimed to evaluate whether a New Zealand-adapted Mediterranean diet (NZMedDiet) affects GI symptom severity in adults at increased cardiometabolic risk, explore the influence of participant characteristics on symptoms, and assess the association between GI symptoms and health-related QoL.MethodsThis secondary analysis used data from a randomized controlled trial of a 12-week NZMedDiet and behavioral intervention in adults with increased cardiometabolic risk. Associations were assessed between the gastrointestinal symptom rating scale (GSRS), the 36-Item Short-Form Survey (SF-36)(assessing QoL), and the NZMedDiet, alongside participant characteristics.ResultsA total of 200 participants were enrolled (mean age 49.9 ± 10.9 years; 62% women), with women reporting significantly higher baseline GI symptom severity scores on average across all GSRS domains except reflux (p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.